<DOC>
	<DOCNO>NCT01364597</DOCNO>
	<brief_summary>This study evaluate safety tolerability brivaracetam pediatric subject epilepsy .</brief_summary>
	<brief_title>Open-label Long-term Study Adjunctive Brivaracetam Pediatric Subjects With Epilepsy</brief_title>
	<detailed_description>This Phase 3 , open-label , single-arm , multicenter , long-term study evaluate safety efficacy brivaracetam ( BRV ) child epilepsy . This study initially design pediatric subject complete previous BRV study . With Protocol Amendment 3 , enrollment expand include additional 100 subject `` directly enrol subject '' ≥4 year &lt; 17 year age partial-onset seizure ( POS ) previously enrol pediatric BRV study . With Protocol Amendment 4 , enrollment `` directly enrol '' subject modify 'up ' additional 100 subject `` least '' 100 subject , keep plan total enrollment approximately 600 subject allow flexibility number patient reach 1 year exposure . The primary objective evaluate long-term safety tolerability BRV . The secondary objective ass efficacy BRV long-term exposure .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Inclusion Criteria Long Term Followup Subjects : Participation previous brivaracetam pediatric epilepsy study expect reasonable benefit longterm administration brivaracetam Signed informed consent form ( ICF ) assent form Directly Enrolled Subjects : Directly enrol subject : Signed ICF assent form Clinical diagnosis POS Minimum 1 concomitant antiepileptic drug ( AED ) stable dose additions/deletions least 7 day prior Screening visit ≥4 year &lt; 17 year Women childbearing potential , sexually active : Adequate Contraceptive method Negative pregnancy test Pregnant nursing female Severe medical , neurological , psychiatric disorder laboratory value , may impact safety subject Poor compliance visit schedule medication intake previous study , applicable</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Brivaracetam</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Child</keyword>
	<keyword>Infant</keyword>
	<keyword>Adolescents</keyword>
</DOC>